CN104480057A - Construction method and application of L-isoleucine producing genetically engineered bacteria - Google Patents

Construction method and application of L-isoleucine producing genetically engineered bacteria Download PDF

Info

Publication number
CN104480057A
CN104480057A CN201410726700.9A CN201410726700A CN104480057A CN 104480057 A CN104480057 A CN 104480057A CN 201410726700 A CN201410726700 A CN 201410726700A CN 104480057 A CN104480057 A CN 104480057A
Authority
CN
China
Prior art keywords
alr
frr
fusa
ilvbn
ppnk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410726700.9A
Other languages
Chinese (zh)
Inventor
王小元
赵建勋
胡晓清
胡瑾瑜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201410726700.9A priority Critical patent/CN104480057A/en
Publication of CN104480057A publication Critical patent/CN104480057A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses L-isoleucine producing genetically engineered bacteria and a construction method and application thereof, belonging to the technical field of genetic engineering and microbial fermentation. According to the method, a knockout vector of the gene alr is constructed and electroporated into the host bacteria to obtain a deficient strain IWJ001 delta alr of the alr. The gene segments are connected to an overexpression vector by use of the PCR amplification genes fusA, frr, ilvBN, ilvA and ippnk and then electroporated into corynebacterium glutamicum IWJ001 delta alr, and the target genetically engineered bacteria, namely L-isoleucine producing genetically engineered bacteria IWJ001 delta alr/pJYW-4-fusA-frr-ilvBN-ilvA-ppnk, are obtained through antibiotic resistance screening. The L-isoleucine producing genetically engineered bacteria constructed by the method disclosed by the invention can be used for increasing the yield of L-isoleucine through fermentation in a shake flask or fermentation tank, and the method is conductive to reducing the difficulty in separation and purification and increasing the yield so as to remarkably reduce the production cost of L-isoleucine.

Description

Construction process and the application of ILE genetic engineering bacterium are produced in one strain
Technical field
The present invention relates to a strain and produce ILE genetic engineering bacterium and construction process thereof, and improve the application of amino acid production, belong to genetically engineered and technical field of microbial fermentation.
Background technology
ILE, also known as L-L-iLeu, chemistry L-α-amino-γ-methylthio-n-butyric acid by name, belongs to that aspartic acid race is nonpolar, the amino acid whose one of water transport property.Owing to there are two chiral carbon atoms in α position and β position, so there are 4 kinds of stereoisomerses, be respectively that D, L, D are other, the other type of L, be present in nature and the Isoleucine with physiological function only has L-type.ILE is extensively present in multiple plant animal protein, it is the one of common 18 seed amino acids, also be one of human body eight seed amino acid, all contain a methyl chains in the molecular structure in addition due to it and L-Leu, Valine and be called as branched-chain amino acid.
ILE is as one of 8 seed amino acids of needed by human, it is the raw material of synthesized human hormone, enzyme, there is the effect promoting protein synthesis and suppress to decompose, but cannot self synthesize in body, grownup needs the ILE absorbing 20 mg/kg (body weight) from the external world every day.Therefore, ILE has a wide range of applications and commercial value in food, medicine, feed and sports health field.
In food service industry, ILE can strengthen the nutrition of some food, and ILE as contained in wheat-flour, glutenin, peanut powder, potato etc. is limiting amino acid, to be fortified.ILE is combined with other amino acid, can improve the form of the food such as bread, biscuit, soft sweets, washmarking, proterties, color and luster, taste, nutrition.ILE and other amino acid ligands make amino acid energy beverage and sports drink, have formation muscle, alleviate muscle fatigue, improve athletic patience, promote the synthesis rate of protein level of skeletal muscle and reduce the degradation rate of albumen, being beneficial to muscle recovery.In addition, ILE also can be made into high fat diet treatment epileptics.
In pharmaceutical industries, be mainly used in preparing Hausmam Amin 20, comprise standard amino acid solution transfusion, the transfusion of therapeutic type high branched-chain amino acid and various oral liquid formulations, for liver cirrhosis patient provides albumen and energy, promote the turnover of hat artery patient myocardium protein, improve appetite and the nutrition of uremic patient, avoid malnutrition, for acute nonsuppurative hepatitis provides albumen and the energy.
In feedstuff industry, ILE has special effect as Animal nutrition, is therefore subject to the extensive concern of investigator.At present, ILE makes fodder additives, saves protein feed, forage component is utilized, and improves efficiency of feed utilization, thus reduces costs.In bean pulp type basal diet, add ILE, the muscle growth of ox can be improved.In pig feed, add ILE can improve the utilization of big porker to methionine(Met).When ILE and other amino acid and albumen together feeding cow, the protein content in milk can be improved.In the feed of lactation type sow, add ILE, food consumption and the lactation metabolism of sow can be improved.The ovulation rate that ILE can improve ewe is added in the ewe feed in rutting sedson.
In health-care industry, ILE can improve the immunizing power of human body, promotes the consumption of body energy, reduces fat quantity, can be used for the preparation of diet pill.Control blood sugar by glucocorticosteroid, reduce central fatigue.In addition, ILE has certain effect to treatment sports type obstacle and wound, can reduce the symptom of tardive dyskinesia, and treatment wound, improves the injured cognitive disorder caused.
Because the available area of ILE is extensive, and new purposes is constantly found, considerably increases market demand.At present, domestic existing producer carries out batch production ILE, but the bacterial strain acid producing ability that these enterprises produce is low, and production technique and production unit lag behind the states such as Japan, and output can not be met the need of market.Therefore, improve bacterial strain throughput, optimization technological process, outfit sophisticated equipment become China assistant officer problem to be solved.
In the present invention, we produce based on bacterium IWJ001 by ILE, construct alrgenetic flaw Host Strains, and gene cluster is have expressed on expression vector pJYW-4 fusA- frr- ilvBN-ilva- ppnk, due on this expression vector with alrgene, compensate for Host Strains alrwithout the need to adding microbiotic, disappearance, therefore can ensure that expression vector is expressed at endobacillary stable existence and composition.The engineering bacteria that the present invention builds improves ILE output.
Summary of the invention
The object of this invention is to provide a strain and produce ILE genetic engineering bacterium and construction process thereof and application, the engineering bacteria that the present invention builds improves ILE output.
Technical scheme of the present invention: ILE genetic engineering bacterium is produced in a strain, its Classification And Nomenclature be Corynebacterium glutamicum ( corynebacterium glutamicum) IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk,be preserved in China typical culture collection center, deposit number: CCTCC NO:M2014529.
Genome is covered by plasmid alrgenetic flaw, thus make expression vector stable existence in the antibiotic-free interpolation situation exercise expressive function in thalline, described bacterial strain comprises alrgene defection type expressive host.
Described expressive host is the gene being knocked encoding alanine racemase alrcorynebacterium glutamicum ( corynebacterium glutamicum).
Described expressive host be by alrknockout carrier is transformed into Corynebacterium glutamicum, is obtained by homologous recombination alrdefective type expressive host, described in alrthe nucleotide sequence of knockout carrier is as shown in SEQ ID NO.1.
First technical problem solved by the invention is, alrdefective type expressive host, its construction process, key step is:
(1) with c. glutamicumiWJ0001 genome is template, respectively with alr-S-(+)/(-) and alr-X-(+)/(-) is for each 1000bp's of primer amplification alrgene upstream and downstream fragment alr-U, alr-D; With pDTW-202(Jinyu Hu, Yanzhen Tan, Yanyan Li, Xiaoqing Hu, Daqing Xu, Xiaoyuan Wang, 2013. Construction and application of an efficient multiple-gene-deletion system in corynebacterium glutamicum.) be template, kan-lox-F/R is primer amplification kanresistance gene fragment. alr-U with xhoi, bamHi enzyme is cut, alr-D with xbai and psti enzyme is cut, kanfragment with bamHi, xbai enzyme is cut, three fragments be connected into together with xhoi and pstpBluescript II SK (+) that I enzyme is cut, the plasmid built namely alrknockout carrier, called after pJXW-1.
(2) will alrknockout carrier transforms Host Strains, is obtained by homologous recombination alrgene defection type expressive host bacterium.
Second technical problem that the present invention will solve is at carrier pJYW-4 expressing gene fusA, frr, ilvBN, ilvA, ppnk, key step is:
(1) increase fusA-frrgene fragment: fusA-frrtwo ends are introduced respectively noti and nhei restriction enzyme site; By PCR primer fusA-frrfragment is connected into the expression vector pJYW-4 cut with same restriction enzyme after cutting with corresponding restriction enzyme, obtain recombinant expression plasmid pJYW-4- fusA- frr;
(2) increase ilvBN-ilvA- ppnkgene fragment, ilvBN-ilvA- ppnktwo ends are introduced respectively sfii and aSci restriction enzyme site; By PCR primer ilvBN-ilvA- ppnkfragment is connected into the expression vector pJYW-4-cut with same restriction enzyme after cutting with corresponding restriction enzyme fusA- frr, obtain recombinant expression plasmid pJYW-4- fusA- frr- ilvBN-ilvA- ppnk;
(3) by recombinant expression plasmid pJYW-4- fusA- frr- ilvBN-ilvA- ppnkproceed to and pass through alrknockout carrier knocks out alrthe corynebacterium glutamicum of gene, obtains genetic engineering bacterium IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk.
Expressing gene fusA- frr- ilvBN-ilvA-ppnk, its nucleotide sequence is respectively: fusAfor SEQ ID NO.2, frrfor SEQ ID NO.3, ilvAfor SEQ ID NO.4, ilvBNfor SEQ ID NO.5, ppnkfor SEQ ID NO.6.
The application of described product ILE genetic engineering bacterium, ILE is produced in fermentation.
Beneficial effect of the present invention: this bacterial strain do not rely on antibiotics resistance can maintain expression vector stable be present in C. glutamicum cells, be beneficial to suitability for industrialized production.And ILE output can be improved by a relatively large margin.
Biological material specimens preservation: Corynebacterium glutamicum ( corynebacterium glutamicum) IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk,be preserved in China typical culture collection center, address Wuhan, China Wuhan University, preservation date on October 29th, 2014, deposit number: CCTCC NO:M2014529.
Accompanying drawing explanation
Fig. 1 alrthe structure of gene knockout carrier pJXW-1.
Fig. 2 expression vector pJYW-4- fusA- frr- ilvBN-ilva- ppnkstructure.
Fig. 3 bacterial strain shake flask fermentation and amino acid production change signal.
The thalli growth amount variation diagram of Fig. 4 bacterial strain tank top fermentation.
Embodiment
Embodiment 1 alrthe structure of knockout carrier pJXW-1
With c. glutamicumiWJ001 genome is template, respectively with alr-S-(+)/(-) and alr-X-(+)/(-) is for each 1000bp's of primer amplification alrgene upstream and downstream fragment alr-U, alr-D; With pDTW-202(Jinyu Hu, Yanzhen Tan, Yanyan Li, Xiaoqing Hu, Daqing Xu, Xiaoyuan Wang, 2013. Construction and application of an efficient multiple-gene-deletion system in corynebacterium glutamicum.) be template, kan-lox-F/R is primer amplification kanresistance gene fragment. alr-U with xhoi, bamHi enzyme is cut, alr-D with xbai and psti enzyme is cut, kanfragment with bamHi, xbai enzyme is cut, three fragments be connected into together with xhoi and pstpBluescript II SK (+) that I enzyme is cut, the plasmid built namely alrknockout carrier, called after pJXW-1(Fig. 2).
The structure of embodiment 2 expression vector
First, with plasmid pDXW-8- fusA- frrfor template, fusA-F, frr-R is primer, amplification fusA- frrgene fragment, fusA- frrtwo ends are introduced respectively noti and nhei restriction enzyme site; By PCR primer fusA- frrfragment is connected into the pJYW-4 cut with same restriction enzyme after cutting with corresponding restriction enzyme, completes expression plasmid and builds pJYW-4- fusA- frr.
With plasmid pDXW-8- ilvBN-ilva- ppnk(Yin L, Zhao J, Chen C, Hu X, Wang X (2014) Enhancing the carbon flux and NADPH supply to increase L-isoleucine production in corynebacterium glutamicum.) be template, ilvBN-F, ppnk-R is primer, amplification ilvBN-ilvA-ppnkgene fragment, ilvBN-ilva- ppnktwo ends are introduced respectively sfii and asci restriction enzyme site; By PCR primer ilvBN-ilva- ppnkfragment is connected into the pJYW-4-cut with same restriction enzyme after cutting with corresponding restriction enzyme fusA- frr, complete expression plasmid and build pJYW-4- fusA- frr- ilvBN-ilvA-ppnk.
Then, by pJYW-4- fusA-frr-ilvBN-ilvA-ppnkproceed to IWJ001 Δ alr, build engineering strain IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk.
Embodiment 3 shake flask fermentation
From preservation strain IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnkglycerine pipe in draw and get a ring bacterium liquid and rule on solid-state activation medium, cultivate 36 h for 30 DEG C.Utilizing transfering loop to be transferred to from scraping one ring lawn the flat board activated is equipped with in 250 mL triangular flasks of 25mL seed culture medium, and 30 DEG C, 200 r/min cultivate 18 h.From cultured seed liquor, draw 2.4 mL bacterium liquid be forwarded to and be equipped with in the 250mL triangular flask of 23mL fermention medium, cultivate 6 h for 30 DEG C, adding final concentration is that 1 mM isopropylthiogalactoside (IPTG) inducible protein is expressed until fermentation ends (t=72h).
Fermentation ends fermented liquid adopts HPLC to measure aminoacids content, utilizes HPLC OPA (o-phthalaldehyde(OPA)) pre-column derivatization method.Centrifugal 30 min of fermented liquid 12000 r/min, supernatant liquor is transferred in a clean EP pipe, dilute 20 times (shaking flasks) or 40 times (fermentor tank) with 5% trichoroacetic acid(TCA), room temperature places 4h, centrifugal 30 min of 12000 r/min, 0.22 μm of aqueous phase pin type frit, now sample directly can go up machine testing.Chromatographic column: Agilent Hypersil ODS 4.0*250mm (5 μm), column temperature: 40 DEG C.Moving phase: aqueous phase A: anhydrous sodium acetate 3.01 g, first water-soluble, then add triethylamine 200 μ L, tetrahydrofuran (THF) 5 mL, ddH 2o constant volume 1 L, 5% acetic acid is adjusted to pH 7.2; Organic phase B: anhydrous sodium acetate 3.01g, ddH 2o constant volume is 200 mL, and 5% acetic acid is adjusted to pH 7.2, and then adds 400 mL methyl alcohol (chromatographically pure) and 400 mL acetonitriles (chromatographically pure), and flow velocity is 1 mL/min.Sample needs to carry out column front derivation before running pillar, and the sample derived enters chromatographic column and carries out gradient elution, and elution program is as follows:
Step Time %A %B
1 0 92 8
2 27 40 60
3 31.5 0 100
4 32 0 100
5 34 0 100
6 35.5 92 8
This experiment used medium:
Activated inclined plane substratum (g/L): Tryptones 10, NaCl 5, yeast extract 5, glucose 5, beef extractive substance 10, deionized water is prepared;
Seed culture medium (g/L): glucose 30, (NH 4) 2sO 45, KH 2pO 41, MgSO 40.5, corn steep liquor 30, utilizes 5 M NaOH solution to regulate pH 7.0;
Fermention medium (g/L): glucose 100, (NH 4) 2sO 435, KH 2pO 41, MgSO 40.5, corn steep liquor 15, deionized water is prepared; 5 M NaOH solution are utilized to regulate pH 7.0; Shake flask fermentation cultivates interpolation 20 g/L CaCO 3for regulating pH.
Fig. 3 is shown in amino acid production change: cultivate through 72h, IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnkisoleucine content be 12.4g/L; Under same culture conditions, IWJ001 Δ alriLE output 7.4 g/L of/pJYW-4, both compare IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnkcomparatively IWJ001 Δ alrits output of/pJYW-4 promotes 67%.
The top fermentation of embodiment 4 tank
From the glycerine pipe of preservation strain, get a ring bacterium liquid rule at solid-state activation medium, cultivate 36 h for 30 DEG C.From the flat board activated, the access of scraping one transfering loop lawn is equipped with in 500 mL triangular flasks of 50mL seed culture medium, and 30 DEG C of 200 r/min cultivates 18 h.Be equipped with being forwarded in 150 mL seed liquor in 3 L automatic fermenters of 1.2 L fermention mediums.Utilize the ammoniacal liquor auto-control pH=7.0 of 50%, utilize cooling circulating water and base hot-plate A.T.C to be 30 DEG C, utilize mixing speed and dissolved oxygen coupling, maintain dissolved oxygen 30%, Ventilation Rate (1.5 vvm).As cultivation 6 h, adding final concentration is that 1 mM IPTG inducible protein is expressed.When the glucose concn in substratum is lower than 20 g/L, utilize peristaltic pump to add the glucose of certain volume, maintain glucose concn near 20 g/L.Fermentation culture 72 h.
IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnkisoleucine content be 28.6g/L; Under same culture conditions, IWJ001 Δ alrisoleucine output 20.3 g/L of/pJYW-4.Both compare IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN- ilva- ppnkcomparatively IWJ001 Δ alrits output of/pJYW-4 promotes 40.9%.
table 1the present invention relates to primer
Primer Sequence (5'-3') Restriction enzyme site
alr-S-(+) ATACTCGAGGTAGCAGACATCGCCGGCCCAG XhoI
alr-S-(-) ATATCTAGACATGCGCGGGAGAAATAACAGC XbaI
alr-X-(+) ACAGGATCCTGGACAAGGCACTTCCTATGG BamHI
alr-X-(-) GGTCTCGAGCAAGATCCAACAAAAGGTTCACT PstI
kan-lox-F ATGGATCCAATACGACTCACTATAGGGCG BamHI
kan-lox-R ACCTCTAGAGCGCAATTAACCCTCACTAAAG XbaI
alr-P-(+) ACGAGATCTCCTTTGTGGTCTGGCATGAAG BglII
alr-P-(-) CACCTGCAGAGACGTCCAAAATCACCACATCGCCAGCTTC AatII
ilvBN-F TTGGCGCGCCTGCTTCTGGCGTCAGGC AscI
ppnk-R TATGGCCGGCGGGGCCTTTTACCCCGCTGACCTGGGAT SfiI
fusA-F TAGCTAGCAGAAGGAGTAAATCGGTGGCTCAAGAAGTGCTTAAG NheI
frr-R ATAAGAATGCGGCCGCTATGGCCGGCGGGGCCTTGGCGCGCCCTAGACCTCCATC NotI
Although the present invention with preferred embodiment openly as above; but it is also not used to limit the present invention, any person skilled in the art, without departing from the spirit and scope of the present invention; all can do various changes and modification, what therefore protection scope of the present invention should define with claims is as the criterion.
<160> 6
 
<210> SEQ ID NO: 1
<211> 1086
<212> DNA
<213> alr
 
<400> 1
atgaacttgc tgaccaccaa aattgacctg gatgccatcg cccataacac gagggtgctt 60
aaacaaatgg cgggtccggc gaagctgatg gcggtggtga aggcgaatgc atataaccat 120
ggcgtagaga aggtcgctcc ggttattgct gctcatggtg cggatgcgtt tggtgtggca 180
actcttgcgg aggctatgca gttgcgtgat atcggcatca gccaagaggt tttgtgttgg 240
atttggacac cggagcagga tttccgcgcc gccattgatc gcaatattga tttggctgtt 300
atttctcccg cgcatgccaa agccttgatc gaaactgatg cggagcatat tcgggtgtcc 360
atcaagattg attctgggtt gcatcgttcg ggtgtggatg agcaggagtg ggagggcgtg 420
ttcagcgcgt tggctgctgc cccgcacatt gaggtcacgg gcatgttcac gcacttggcg 480
tgcgcggatg agccagagaa tccggaaact gatcgccaaa ttattgcttt tcgacgcgcc 540
cttgcgctcg cccgcaagca cgggcttgag tgcccggtca accacgtatg caactcacct 600
gcattcttga ctcgatctga tttacacatg gagatggtcc gaccgggttt ggccttttat 660
gggttggaac ccgtggcggg actggagcat ggtttgaagc cggcgatgac gtgggaggcg 720
aaggtgagcg tcgtaaagca aattgaagct ggacaaggca cttcctatgg cctgacctgg 780
cgcgctgagg atcgcggctt tgtggctgtg gtgcctgcgg gctatgccga tggcatgccg 840
cggcatgccc aggggaaatt ctccgtcacg attgatggcc tggactatcc gcaggttggg 900
cgcgtatgca tggatcagtt cgttatttct ttgggcgaca atccacacgg cgtggaagct 960
ggggcgaagg ccgtgatatt cggtgagaat gggcatgacg caactgattt tgcggagcgt 1020
ttagacacca ttaactatga ggtagtgtgc cgaccaaccg gccgaactgt ccgcgcatat 1080
gtttaa 1086
 
<210> SEQ ID NO: 2
<211> 2130
<212> DNA
<213> fusA
 
<400> 2
gtggcacaag aagtgcttaa gatctaaaca aaggtccgca acatcggcat catggcgcac 60
atcgatgctg gtaagaccac gaccaccgaa cgcatcctct tctacaccgg catcaaccgt 120
aaggtcggtg agacccacga cggtggcgca accaccgact ggatggagca ggagaaggaa 180
cgcggcatca ccattacctc cgccgcggtt acctgtttct gggataacaa ccaggtcaac 240
atcattgaca cccctggcca cgttgacttc accgttgagg ttgagcgttc cctccgcgtg 300
cttgacggcg cagttgctgt gttcgacggc aaggaaggcg ttgagccaca gtctgagcag 360
gtttggcgtc aggctaccaa gtacgacgtt ccacgtatct gcttcgtgaa caagatggac 420
aagctcggtg ctgacttcta cttcaccgtt ggcaccatcg aggaccgcct gggtgcaaag 480
ccattggtta tgcagctccc aatcggtgct gaggacaact tcgacggcgt catcgacctt 540
cttgaaatga aggcactgac ctggcgtgga gttaccccaa ttggtaccga agctaccgtt 600
gaggagatcc cagcagagct cgcagaccgc gcagctgagt accgtgagaa gcttctcgag 660
accgttgcag agtccgacga agagctcatg gagaagtact tcggtggcga agagctcagc 720
atcgctgaga tcaaggcagc tatccgtaag atggttgtta actctgagat ctaccctgtt 780
tactgtggca ccgcctacaa gaacaagggc atccagccac tgctcgacgc agtcgttgac 840
ttcctgcctt ccccactgga tctcggcgag accaagggca ctgacgttaa ggatcctgag 900
aaggttctga cccgtaagcc ttccgacgaa gagccactgt ctgcacttgc attcaagatt 960
gcagctcacc cattcttcgg taagctgacc ttcgttcgtc tgtactccgg caaggttgag 1020
ccaggcgagc aggttcttaa ctccaccaag aacaagaagg aacgcattgg taagctgttc 1080
cagatgcacg ccaacaagga aaaccctgtt gaggttgcac acgctggtaa catctacgcg 1140
ttcatcggcc tgaaggacac caccaccggt gacaccctct gtgacgcaaa cgctccaatc 1200
attcttgagt ccatggactt cccggatcca gttatccagg ttgctattga gcctaagacc 1260
aagtctgacc aggagaagct cggcgtagct atccagaagc ttgctgaaga agacccaacc 1320
ttcaccgttc acttggacga tgagtccggc cagaccgtca ttggcggcat gggcgagctg 1380
cacctcgatg ttcttgttga ccgcatgaag cgcgagttca aggttgaggc aaacatcggt 1440
gacccacagg ttgcttaccg tgagaccatc cgtaagcctg ttgagtccct cagctacacc 1500
cacaagaagc agactggtgg ttccggtcag ttcgctaagg tcatcatcac cattgagcct 1560
tacgcacctg aggcagacga gcttgaagag ggcgagtccg caatctacaa gttcgagaac 1620
gctgtcaccg gtggtcgtgt tccacgtgaa tacatcccat ccgttgacgc tggtatccag 1680
gacgcaatgc agtacggctt cctggctggc tacccactgg ttaacgtcaa ggcaaccctt 1740
gaagatggcg cttaccacga cgttgactcc tctgaaatgg ccttcaagct cgccggttcc 1800
caggcgttca aggaagctgt tgcaaaggca aagccagtcc tcctcgagcc aatcatgtcc 1860
gttgaaatca ccactcctga ggagtacatg ggtgaagtca tcggtgacgt gaactcccgc 1920
cgtggccaga tcgcttccat ggatgaccgt gcaggcgcca agctggttaa ggctaaggtt 1980
ccactgtctc agatgttcgg ttacgtcggt gaccttcgct ctaagaccca gggtcgtgca 2040
aactactcca tggtcttcga ttcctacgct gaggtcccag ccaacgttgc cgcagatgtt 2100
attgctgagc gcaacggcac cgcttcctaa 2130
                                                       
<210> SEQ ID NO: 3
<211> 558
<212> DNA
<213> frr
 
<400> 3
atgattgatg aaattctgtt cgaagcggaa gagcgcatga ccgcaacggt cgagcacacc 60
cgcgaagact tgaccaccat tcgtaccggt cgcgcaaacc cggctatgtt caacggtgtc 120
atggctgaat actacggcgt gcctactcct attactcaga tgtcaggcat cactgttcca 180
gagcctcgca tgctgctgat caagccttat gagatgtctt ccatgcaggt cattgagaat 240
gctatccgta actctgacct tggtgttaac cccaccaacg atggccaggt gctgcgtgtg 300
accatcccac agcttactga agagcgtcgt aaggacatgg tcaagcttgc taagggtaag 360
ggcgaagacg gcaagattgc cattcgtaac atccgccgca agggcatgga ccagctaaag 420
aagctgcaaa aagatggcga cgctggcgaa gatgaagtac aggcagcaga aaaagaacta 480
gataaagtca ccgctggttt tgttgcgcag gtcgatgaag tcgttgctcg caaggaaaag 540
gaactgatgg aggtctag 558
 
<210> SEQ ID NO: 4
<211> 1311
<212> DNA
<213> ilvA
 
<400> 1
atgagtgaaa catacgtgtc tgagaaaagt ccaggagtga tggctagcgg agcggagctg 60
attcgtgccg ccgacattca aacggcgcag gcacgaattt cctccgtcat tgcaccaact 120
ccattgcagt attgccctcg tctttctgag gaaaccggag cggaaatcta ccttaagcgt 180
gaggatctgc aggatgttcg ttcctacaag atccgcggtg cgctgaactc tggagcgcag 240
ctcacccaag agcagcgcga tgcaggtatc gttgccgcat ctgcaggtaa ccatgcccag 300
ggcgtggcct atgtgtgcaa gtccttgggc gttcagggac gcatctatgt tcctgtgcag 360
actccaaagc aaaagcgtga ccgcatcatg gttcacggcg gagagtttgt ctccttggtg 420
gtcactggca ataacttcga cgaagcatcg gctgcagcgc atgaagatgc agagcgcacc 480
ggcgcaacgc tgatcgagcc tttcgatgct cgcaacaccg tcatcggtca gggcaccgtg 540
gctgctgaga tcttgtcgca gctgacttcc atgggcaaga gtgcagatca cgtgatggtt 600
ccagtcggcg gtggcggact tcttgcaggt gtggtcagct acatggctga tatggcacct 660
cgcactgcga tcgttggtat cgaaccagcg ggagcagcat ccatgcaggc tgcattgcac 720
aatggtggac caatcacttt ggagactgtt gatccctttg tggacggcgc agcagtcaaa 780
cgtgtcggag atctcaacta caccatcgtg gagaagaacc agggtcgcgt gcacatgatg 840
agcgcgaccg agggcgctgt gtgtactgag atgctcgatc tttaccaaaa cgaaggcatc 900
atcgcggagc ctgctggcgc gctgtctatc gctgggttga aggaaatgtc ctttgcacct 960
ggttctgtcg tggtgtgcat catctctggt ggcaacaacg atgtgctgcg ttatgcggaa 1020
atcgctgagc gctccttggt gcaccgcggt ttgaagcact acttcttggt gaacttcccg 1080
caaaagcctg gtcagttgcg tcacttcctg gaagatatcc tgggaccgga tgatgacatc 1140
acgctgtttg agtacctcaa gcgcaacaac cgtgagaccg gtactgcgtt ggtgggtatt 1200
cacttgagtg aagcatcagg attggattct ttgctggaac gtatggagga atcggcaatt 1260
gattcccgtc gcctcgagcc gggcacccct gagtacgaat acttgaccta a 1311
 
<210> SEQ ID NO: 5
<211> 2413
<212> DNA
<213> ilvBN
<400> 5
gtgaatgtgg cagcttctca acagcccact cccgccacgg ttgcaagccg tggtcgatcc 60
gccgcccctg agcggatgac aggtgcaaag gcaattgttc gatcgctcga ggagcttaac 120
gccgacatcg tgttcggtat tcctggtggt gcggtgctac cggtgtatga cccgctctat 180
tcctccacaa aggtgcgcca cgtcttggtg cgccacgagc agggcgcagg ccacgcagca 240
accggctacg cgcaggttac tggacgcgtt ggcgtctgca ttgcaacctc tggcccagga 300
gcaaccaact tggttacccc aatcgctgat gcaaacttgg actccgttcc catggttgcc 360
atcaccggcc aggtcggaag tggcctgctg ggtaccgacg ctttccagga agccgatatc 420
cgcggcatca ccatgccagt gaccaagcac aacttcatgg tcaccaaccc taacgacatt 480
ccacaggcat tggctgaggc attccacctc gcgattactg gtcgccctgg ccctgttctg 540
gtggatattc ctaaggatgt ccagaacgct gaattggatt tcgtctggcc accaaagatc 600
gacctgccag gctaccgccc agtttcaaca ccacatgctc gccagatcga gcaggcagtc 660
aagctgatcg gtgaggccaa gaagcccgtc ctttacgttg gtggtggcgt aatcaaggct 720
gacgcacacg aagagcttcg tgcgttcgct gagtacaccg gcatcccagt tgtcaccacc 780
ttgatggctt tgggtacttt cccagagtct cacgagctgc acatgggtat gccaggcatg 840
catggcactg tgtccgctgt tggtgcactg cagcgcagcg acctgctgat tgctatcggc 900
tcccgctttg atgaccgcgt caccggtgac gttgacacct tcgcgcctga cgccaagatc 960
attcacgccg acattgatcc tgccgaaatc ggcaagatca agcaggttga ggttccaatc 1020
gtgggcgatg cccgcgaagt tcttgctcgt ctgctggaaa ccaccaaggc aagcaaggca 1080
gagaccgagg acatctccga gtgggttgac tacctcaagg gcctcaaggc acgtttcccg 1140
cgtggctacg acgagcagcc aggcgatctg ctggcaccac agtttgtcat tgaaaccctg 1200
tccaaggaag ttggccccga cgcaatttac tgcgccggcg ttggccagca ccaaatgtgg 1260
gcagctcagt tcgttgactt tgaaaagcca cgcacctggc tcaactccgg tggactgggc 1320
accatgggct acgcagttcc tgcggccctt ggagcaaagg ctggcgcacc tgacaaggaa 1380
gtctgggcta tcgacggcga cggctgtttc cagatgacca accaggaact caccaccgcc 1440
gcagttgaag gtttccccat taagatcgca ctaatcaaca acggaaacct gggcatggtt 1500
cgccaatggc agaccctatt ctatgaagga cggtactcaa atactaaact tcgtaaccag 1560
ggcgagtaca tgcccgactt tgttaccctt tctgagggac ttggctgtgt tgccatccgc 1620
gtcaccaaag cggaggaagt actgccagcc atccaaaagg ctcgagagat caacgaccgc 1680
ccagtagtca tcgacttcat cgtcggtgaa gacgcacagg tatggccaat ggtgtctgct 1740
ggatcatcca actccgatat ccagtacgca ctcggattgc gcccattctt tgatggtgat 1800
gaatctgcag cagaagatcc tgccgacatt cacgaagccg tcagcgacat tgatgccgcc 1860
gttgaatcga ccgaggcata aggagagacc caagatggct aattctgacg tcacccgcca 1920
catcctgtcc gtactcgttc aggacgtaga cggaatcatt tcccgcgtat caggtatgtt 1980
cacccgacgc gcattcaacc tcgtgtccct cgtgtctgca aagaccgaaa cacacggcat 2040
caaccgcatc acggttgttg tcgacgccga cgagctcaac attgagcaga tcaccaagca 2100
gctcaacaag ctgatccccg tgctcaaagt cgtgcgactt gatgaagaga ccactatcgc 2160
ccgcgcaatc atgctggtta aggtctctgc ggacagcacc aaccgtccgc agatcgtcga 2220
cgccgcgaac atcttccgcg cccgagtcgt cgacgtggct ccagactctg tggttattga 2280
atccacaggc accccaggca agctccgcgc actgcttgac gtgatggaac cattcggaat 2340
ccgcgaactg atccaatccg gacagattgc actcaaccgc ggtccgaaga ccatggctcc 2400
ggccaagatc taa 2413
<210> SEQ ID NO: 6
<211> 963
<212> DNA
<213> ppnk
<400> 6
atgactgcac ccacgaacgc tggggaactc aggcgagttt tgctggttcc acacaccggg 60
cgttcttcca atattgaatc cgccatcttg gcagccaagc tgctcgacga tgctggaatc 120
gatgtgaggg tgctgatcaa tgatgcagat gatccaattg cagagcactc cgttttaggc 180
cgtttcaccc atgtcaggca cgctgcagac gccgctgacg gcgcagaact agttctggtg 240
ctgggtggag atggcacctt cctccgcgca gcagatatgg cccacgctgt tgatttgcct 300
gttctgggca tcaacctagg ccatgtggga ttcttggctg aatgggagtc tgactcactt 360
gaagaggcac tcaaacgtgt gatcgaccgc gattaccgta ttgaagatcg catgacctta 420
actgtcgttg tcctagacgg cggtggagaa gaaatcggcc gaggctgggc tctcaatgag 480
gtcagtattg aaaacttaaa ccgcagggga gtgctcgatg caaccctcga ggtagatgca 540
cgaccagttg cttcctttgg ttgcgatggc gtgctgattt ccaccccaac cggctccacc 600
gcttatgcat tttccgccgg tggtcctgta ctgtggccag aactcgatgc catcttggtg 660
gttcctaata acgcccacgc gctgtttacc aaaccgctgg ttgtgagccc aaaatccacc 720
gtagctgtgg aatccaattc agatacttca gcagcgatgg ccgtcatgga tggtttccgt 780
cccattccta tgcctccagg atcccgtgtt gaggtcacca ggggtgagcg tcccgtgcgt 840
tgggtgaggc ttgattcttc accgtttacc gaccgacttg tgagcaaatt aaggctcccc 900
gttaccggtt ggcggggtcc gcaaaaacag gcggaaaata aagatcccag gtcagcgggg 960
taa 963
 

Claims (8)

1. ILE genetic engineering bacterium is produced in a strain, its Classification And Nomenclature be Corynebacterium glutamicum ( corynebacterium glutamicum) IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk,be preserved in China typical culture collection center, deposit number: CCTCC NO:M2014529.
2. produce ILE genetic engineering bacterium according to claim 1, it is characterized in that, cover genome by plasmid alrgenetic flaw, thus make expression vector stable existence in the antibiotic-free interpolation situation exercise expressive function in thalline, described bacterial strain comprises alrgene defection type expressive host.
3. produce ILE genetic engineering bacterium according to claim 2, it is characterized in that, described expressive host is the gene being knocked encoding alanine racemase alrcorynebacterium glutamicum ( corynebacterium glutamicum).
4. according to Claims 2 or 3, produce ILE genetic engineering bacterium, it is characterized in that, described expressive host be by alrknockout carrier is transformed into corynebacterium glutamicum, is obtained by homologous recombination alrdefective type expressive host, described in alrthe nucleotide sequence of knockout carrier is as SEQ ID NO.1.
5. produce ILE genetic engineering bacterium according to claim 4, described in alrdefective type expressive host, its construction process, is characterized in that, key step is:
(1) with c. glutamicumiWJ001 genome is template, respectively with alr-S-(+)/(-) and alr-X-(+)/(-) is for each 1000bp's of primer amplification alrgene upstream and downstream fragment alr-U and alr-D; Take pDTW-202 as template, kan-lox-F/R is primer amplification kanresistance gene fragment; alr-U with xhoi, bamHi enzyme is cut, alr-D with xbai and psti enzyme is cut, kanfragment with bamHi, xbai enzyme is cut, three fragments be connected into together with xhoi and pstpBluescript II SK (+) that I enzyme is cut, the plasmid built namely alrknockout carrier, called after pJXW-1;
(2) will alrknockout carrier transforms Host Strains, is obtained by homologous recombination alrgene defection type expressive host bacterium.
6. according to claim 1 or 5, produce ILE genetic engineering bacterium, it is characterized in that, coexpression gene fusA- frr- ilvBN-ilvA-ppnk, its nucleotide sequence is respectively: fusAfor SEQ ID NO.2, frrfor SEQ ID NO.3, ilvAfor SEQ ID NO.4, ilvBNfor SEQ ID NO.5, ppnkfor SEQ ID NO.6.
7. according to claim 1,5 or 6, produce ILE genetic engineering bacterium, described expression vector pJYW-4- fusA- frr- ilvBN-ilvA- ppnk, its construction process, is characterized in that, key step is:
(1) increase fusA-frrgene fragment: fusA-frrtwo ends are introduced respectively noti and nhei restriction enzyme site; By PCR primer fus-frrfragment is connected into the expression vector pJYW-4 cut with same restriction enzyme after cutting with corresponding restriction enzyme, obtain recombinant expression plasmid pJYW-4- fusA- frr;
(2) increase ilvBN- ilva- ppnkgene fragment: ilvBN- ilva- ppnktwo ends are introduced respectively sfii and asci restriction enzyme site; By PCR primer ilvBN- ilva- ppnkfragment is connected into the expression vector pJYW-4-cut with same restriction enzyme after cutting with corresponding restriction enzyme fusA- frr, obtain recombinant expression plasmid pJYW-4- fusA- frr- ilvBN-ilvA- ppnk;
(3) by recombinant expression plasmid pJYW-4- fusA-frr-ilvBN-ilvA-ppnkproceed to and pass through alrknockout carrier knocks out alrthe corynebacterium glutamicum of gene, obtains genetic engineering bacterium IWJ001 Δ alr/ pJYW-4- fusA- frr- ilvBN-ilva- ppnk.
8. produce the application of ILE genetic engineering bacterium described in claim 1,5 or 6, it is characterized in that for the product ILE that ferments.
CN201410726700.9A 2014-12-04 2014-12-04 Construction method and application of L-isoleucine producing genetically engineered bacteria Pending CN104480057A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410726700.9A CN104480057A (en) 2014-12-04 2014-12-04 Construction method and application of L-isoleucine producing genetically engineered bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410726700.9A CN104480057A (en) 2014-12-04 2014-12-04 Construction method and application of L-isoleucine producing genetically engineered bacteria

Publications (1)

Publication Number Publication Date
CN104480057A true CN104480057A (en) 2015-04-01

Family

ID=52754666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410726700.9A Pending CN104480057A (en) 2014-12-04 2014-12-04 Construction method and application of L-isoleucine producing genetically engineered bacteria

Country Status (1)

Country Link
CN (1) CN104480057A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105886431A (en) * 2016-04-27 2016-08-24 天津科技大学 Corynebacterium glutamicum and method for producing high-yield isoleucine with same
CN106701648A (en) * 2016-12-13 2017-05-24 武汉远大弘元股份有限公司 Genetically engineered bacterium for realizing high yield of L-isoleucine as well as construction method and application of genetically engineered bacterium
WO2018099452A1 (en) 2016-12-02 2018-06-07 武汉远大弘元股份有限公司 L-isoleucine-producing corynebacterium glutamicum fermentation medium and culture method
CN109554324A (en) * 2018-12-14 2019-04-02 江南大学 The brevibacterium flavum recombinant bacterium and its construction method of one plant of production l-Isoleucine
CN111321100A (en) * 2020-02-28 2020-06-23 江南大学 Corynebacterium glutamicum engineering bacterium for producing L-isoleucine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101386829A (en) * 2008-10-20 2009-03-18 中国农业大学 Avid kyowamycin genetic engineering bacterium and use thereof
CN103834679A (en) * 2014-02-20 2014-06-04 江南大学 Corynebacteria expression system without depending on antibiotic being selection pressure

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101386829A (en) * 2008-10-20 2009-03-18 中国农业大学 Avid kyowamycin genetic engineering bacterium and use thereof
CN103834679A (en) * 2014-02-20 2014-06-04 江南大学 Corynebacteria expression system without depending on antibiotic being selection pressure

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YIN L: "Enhancing the carbon flux and NADPH supply to increase L-isoleucine production in Corynebacterium glutamicum", 《BIOTECHNOLOGY AND BIOPROCESS ENGINEERING》 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105886431A (en) * 2016-04-27 2016-08-24 天津科技大学 Corynebacterium glutamicum and method for producing high-yield isoleucine with same
CN105886431B (en) * 2016-04-27 2019-05-10 天津科技大学 The method of one plant of corynebacterium glutamicum and its high yield isoleucine
WO2018099452A1 (en) 2016-12-02 2018-06-07 武汉远大弘元股份有限公司 L-isoleucine-producing corynebacterium glutamicum fermentation medium and culture method
US11319563B2 (en) 2016-12-02 2022-05-03 Wuhan Grand Hoyo Co., Ltd. L-isoleucine-producing corynebacterium glutamicum fermentation medium and culture method
CN106701648A (en) * 2016-12-13 2017-05-24 武汉远大弘元股份有限公司 Genetically engineered bacterium for realizing high yield of L-isoleucine as well as construction method and application of genetically engineered bacterium
CN106701648B (en) * 2016-12-13 2019-09-20 武汉远大弘元股份有限公司 The genetic engineering bacterium and its construction method of one plant height production l-Isoleucine and application
CN109554324A (en) * 2018-12-14 2019-04-02 江南大学 The brevibacterium flavum recombinant bacterium and its construction method of one plant of production l-Isoleucine
CN111321100A (en) * 2020-02-28 2020-06-23 江南大学 Corynebacterium glutamicum engineering bacterium for producing L-isoleucine
CN111321100B (en) * 2020-02-28 2022-03-25 江南大学 Corynebacterium glutamicum engineering bacterium for producing L-isoleucine

Similar Documents

Publication Publication Date Title
CN109247447B (en) Yeast hydrolysate for replacing plasma protein powder to produce milk replacer and preparation method thereof
CN104480057A (en) Construction method and application of L-isoleucine producing genetically engineered bacteria
CN109198167B (en) Feed yeast hydrolysate and preparation method and application thereof
CN101897317A (en) Culture method of medicated worm grass pigs
CN102578370A (en) Method for preparing biological feed by using cordyceps culture medium wastes as main raw materials
CN110521856A (en) The production method of the diligent energy property small peptide of one boar
CN106520802A (en) GAD gene for increasing stress tolerance of lactic acid bacteria and application thereof
CN101103764A (en) Method for preparing liquid or semi-solid ferment complete feed containing rich probiotics and polypeptide
CN111733117B (en) Bacillus marinus for producing antibacterial peptide and fermentation method and application thereof
CN106035988B (en) Production method of arginine active peptide powder for livestock and poultry
CN101427838B (en) Preparation of fermentation type oyster milk
CN108244400A (en) A kind of compound feed for snakeheads and preparation method thereof
CN103960462B (en) Saccharomyces cerevisiae is utilized to prepare the method for polypeptide feed
CN105331570A (en) Blue alga engineering bacterium containing crucian IFN interferon and application
CN110004192A (en) A kind of method of preparing granular type threonine
CN104970248A (en) A fish feeding method using fermented beans
CN105995216A (en) Lysozyme-based fish feed
CN102925505B (en) Method for preparing highly-purified L-Lysine sulphate through one-time fermentation
CN104212756B (en) The construction method of one plant of overexpression fusA genetic engineering bacterium and its application
CN116622513A (en) Chlorella, chlorella powder and preparation method thereof
CN105779317A (en) Pichia pastoris strain with high methanol protein yield and application
CN110506839A (en) A kind of feather flour additive agent, preparation method and applications
CN103262947A (en) Preparation method of cow milk production increasing biological fermentation peptide additive, and application method of additive
CN116762898B (en) Prawn immunopotentiator based on CpG oligonucleotide tandem molecules and application thereof
CN109355325A (en) The symbiosis production. art of particle threonine and granule protein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150401